Consistent with this observation, common breast and ovarian cancer susceptibility single-nucleotide polymorphisms (SNPs), identified through genome-wide association studies (GWAS) in the general population, have been shown to modify breast and ovarian cancer risks for BRCA1/2 carriers.3–7. The gene discussed is BRCA1; the disease is ovarian carcinoma.